Publications

Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis.

Eur J Epidemiol
Yang Z, Toh S, Li X, Edwards D, Brayne C, Mant J

ISPE-endorsed guidance in using electronic health records for comparative effectiveness research in COVID-19: opportunities and trade-offs.

Clin Pharmacol Ther
Sarri G, Bennett D, Debray T, Deruaz-Luyet A, Soriano Gabarró M, Largent JA, Li X, Liu W, Lund JL, Moga DC, Gokhale M, Rentsch CT, Wen X, Yanover C, Ye Y, Yun H, Zullo AR, Lin KJ

Analysis of Reported Voting Behaviors of US Physicians, 2000-2020.

JAMA Netw Open
Ahmed A, Chouairi F, Li X

Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: CON.

Kidney360
Kshirsagar AV, Li X

Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care.

J Am Soc Nephrol
Adimadhyam S, Barreto EF, Cocoros NM, Toh S, Brown JS, Maro JC, Corrigan-Curay J, Dal Pan GJ, Ball R, Martin D, Nguyen M, Platt R, Li X

Suitability of administrative claims databases for bariatric surgery research - is the glass half-full or half-empty?

BMC Med Res Methodol
Li X, Lewis KH, Callaway K, Wharam JF, Toh S

At the Crossroads for Intravenous Iron Dosing.

J. Am. Soc. Nephrol.
Kshirsagar AV, Li X, Robinson BM, Brookhart MA

Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events.

Infect Control Hosp Epidemiol
Li X, Klompas M, Menchaca JT, Young JG

Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients.

Adv Chronic Kidney Dis
Kshirsagar AV, Li X

Safety of Dynamic Intravenous Iron Administration Strategies in Hemodialysis Patients.

Clin J Am Soc Nephrol
Li X, Cole SR, Kshirsagar AV, Fine JP, Stürmer T, Brookhart MA

A Pivot Towards Moderating Intravenous Iron Therapy in Hemodialysis.

Am. J. Kidney Dis.
Li X, Kshirsagar AV

Privacy-Protecting Analytical Methods Using Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks.

Am. J. Epidemiol.
Li X, Fireman BH, Curtis JR, Arterburn DE, Fisher DP, Moyneur É, Gallagher M, Raebel MA, Nowell WB, Lagreid L, Toh S

Lower Cancer Incidence-Warfarin Effect or Immortal Time Bias?

JAMA Intern Med
Li X, Lund JL, Toh S

Rest Easy with Intravenous Iron for Dialysis Patients? High Dose IV Iron Safety.

Clin J Am Soc Nephrol
Li X, Kshirsagar AV

Primary non-adherence and the new-user design.

Pharmacoepidemiol Drug Saf
Li X, Cole SR, Westreich D, Brookhart MA

Estimating Effects of Dynamic Treatment Strategies in Pharmacoepidemiologic Studies with Time-varying Confounding: A Primer.

Curr Epidemiol Rep
Li X, Young JG, Toh S

Evidence of sample use among new users of statins: implications for pharmacoepidemiology.

Med Care
Li X, Stürmer T, Brookhart MA

Safety of intravenous iron in hemodialysis patients.

Hemodial Int
Li X, Kshirsagar AV, Brookhart MA

What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Balancing Benefits and Safety with Intravenous Iron Treatment.

Semin Dial
Alan Brookhart M, Li X, Kshirsagar AV

Use of combination antihypertensive therapy initiation in older Americans without prevalent cardiovascular disease.

J Am Geriatr Soc
Li X, Camelo Castillo W, Stürmer T, Pate V, Gray CL, Simpson RJ, Setoguchi S, Hanson LC, Jonsson Funk M